Michael Dominguez, MD
Family Medicine · San Antonio, TXNPI 1689674509
Payments from drug & device makers
Across 13 payments — averaging $13,060 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$147K
- Sanofi-aventis U.S. LLC$20K
- Kowa Research Institute, Inc.$3K
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 7 | $147,273 |
| Sanofi-aventis U.S. LLC | 4 | $19,615 |
| Kowa Research Institute, Inc. | 2 | $2,888 |
How this compares
$169,775 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 115 | $149,147 |
| OzempicSemaglutide | 89 | $129,238 |
| JardianceEmpagliflozin | 96 | $126,881 |
| EliquisApixaban | 68 | $63,341 |
| MyrbetriqMirabegron | 59 | $54,958 |
| JanuviaSitagliptin Phosphate | 32 | $50,128 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 30 | $43,587 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 40 | $43,026 |
| Humalog Kwikpen U-200Insulin Lispro | 17 | $36,724 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 35 | $33,188 |
| LinzessLinaclotide | 22 | $26,394 |
| RybelsusSemaglutide | 12 | $22,057 |
| Tresiba Flextouch U-100Insulin Degludec | 19 | $16,410 |
| MounjaroTirzepatide | 14 | $15,172 |
| XareltoRivaroxaban | 13 | $10,419 |
Paid to pharmacies, not to this prescriber.
Other family medicine in San Antonio
- Douglas DenhamSan Antonio$68.5M
- George AtieeSan Antonio$19.9M
- Leonel ReyesSan Antonio$4.3M
- Brian MacgillivraySan Antonio$3.2M
- Juan GarzaSan Antonio$2.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.